18.19
18.19 (0.27%)
As of Mar 06, 2024
Celcuity Inc. [CELC]
Source:
Company Overview
Celcuity Inc is a clinical-stage biotechnology company focused on development of targeted therapies for treatment of multiple solid tumor indications. Our lead therapeutic candidate is gedatolisib, a pan-PI3K/mTOR inhibitor.
| Country | United States |
| Headquarters | minneapolis, minnesota |
| Phone Number | 763-392-0767 |
| Industry | services |
| CEO | Brian F. Sullivan |
| Website | www.celcuity.com |